홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VSTM
#2881
Verastem, Inc.
6.1
4
USD
+8.48%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+8.48%
월간 변동
+9.45%
6달 변화
-31.40%
년간 변동율
+28.18%
이전 종가
5.6
6
Open
6.1
4
Bid
Ask
Low
6.1
4
High
6.1
4
양
68
마켓
주식
헬스케어
VSTM
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
14.31 M
15.53 M
16.72 M
25.3 M
51.49 M
87.84 M
—
Valuation ratios
Enterprise value
301.35 M
363.9 M
35.94 M
173.6 M
219.62 M
549.96 M
1.54 B
Price to earnings ratio
-4.84
-5
-1.1
-2.11
-1.41
-2.56
-7.48
Price to sales ratio
3.69
174.15
0.03
70.51
18.46
17.31
225.66
Price to cash flow ratio
-9.75
-6.68
-0
-2.12
-1.76
-3.89
-11.33
Price to book ratio
2.83
4.08
0
3.19
-6.39
9.35
-18.85
EBITDA 비율에 대한 기업 가치
-31.18
-6.95
-0.13
-1.42
-1.54
-2.87
-7.94
Profitability ratios
Return on assets %
-0.44
-0.66
-0.78
-0.58
-1.29
-0.85
-1.22
Return on equity %
-0.59
-0.81
-1.56
-1.52
4.52
-3.66
6.66
Return on invested capital %
-558.36
-3 623.48
-7 730.47
-5 137.05
-6 190.86
-2 914.79
-3 718.67
Gross margin %
99.1
100
100
0
100
97.74
389.83
Operating margin %
-55.76
-2 991.18
-2 809.59
-3 547.15
-1 149.56
-550.33
-227.45
EBITDA margin %
-10.79
-2 526.64
-2 796.26
—
-1 149.35
-533
—
Net margin %
-76.51
-3 468.1
-2 843.3
-3 365.45
-1 306.37
-677.59
-5 131.02
Liquidity ratios
Quick ratio
—
—
—
—
—
3.07
—
Current ratio
8.48
5.69
4.29
5.45
3.07
3.09
12.63
Inventory turnover
—
—
—
—
—
0.28
—
Asset turnover
0.59
0.02
0.03
0
0.08
0.18
0.16
Solvency ratios
Debt to assets ratio
0.02
0.03
0.28
0.28
0.42
0.31
1.7
Debt to equity ratio
0.03
0.04
0.57
0.72
-1.46
1.34
-3.92
Long term debt to total assets ratio
0
0
0.26
0.27
0.4
0.31
1.68
Long term debt to total equity ratio
0
0
0.52
0.7
-1.41
1.33
-3.86
Per share metrics
Operating cash flow per share
-2.62
-3.68
-3 945.57
-3.92
-2.93
-1.98
-2.08
EBIT per share
-3.86
-4.23
-4 519.63
-4.18
-3.22
-2.45
-2.56
EBITDA per share
-0.75
-3.57
-4 498.19
-4.22
-3.22
-2.38
-2.52
Total debt per share
0.27
0.22
1 660.07
1.88
1.18
1.11
4.57
Cash per share
11.54
6.9
5 446.83
6.22
2.49
2.96
9.23
Net current asset value per share
11.34
7.28
5 754.8
6.52
2.66
3.22
9.98
Tangible book value per share
9.02
6.02
2 936.64
2.6
-0.81
0.59
-0.18
Working capital per share
10.01
6
4 412.43
5.32
1.79
2.18
6.79
Book value per share
9.02
6.02
2 936.64
2.6
-0.81
0.83
0.5
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
뉴스
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)
Verastem, BTIG ’매수’ 등급 시작, 목표 주가 19달러 제시
Verastem stock initiated at Buy by BTIG with $19 price target
Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?
제퍼리스, Verastem 목표 주가 유지…출시 순항 평가
Jefferies reiterates Verastem stock rating on launch progress
Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript
Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com